At room temperature, common airborne contaminants introduced during needle draws
Preclinical data suggests AOD9604 shifts the metabolic balance toward burning fatty acids for energy rather than storing them, with effects observed particularly in visceral adipose tissue
Enhances insulin sensitivity, improving glucose metabolism Suppresses appetite and reduces food cravings, aiding in lower calorie intake Slows gastric emptying, prolonging satiety and reducing overeating Promotes significant weight loss, even in individuals with obesity-related conditions Typical Dosage: Start with 2.5 mg once weekly, gradually 515 mg depending on patient response and tolerance Administration: Subcutaneous injection, typically in the abdomen, thigh, or upper arm Side Effects Nausea and vomiting Fatigue and mild dizziness Gastrointestinal issues Possible hypoglycemia when combined with other diabetes medications Injection site reactions, redness or irritation 3
compounding pharmacies and are provided only after a valid prescription from a licensed clinician Semaglutide-containing medications have important safety considerations, and reported side effects can vary from person to person
